Severe dopaminergic neuron loss in rhesus monkey brain impairs morphine-induced conditioned place preference.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 4600774)

Published in Front Behav Neurosci on October 12, 2015

Authors

Ting Yan1, Joshua Dominic Rizak1, Jianhong Wang2, Shangchuan Yang2, Yuanye Ma3, Xintian Hu3

Author Affiliations

1: Key Laboratory of Animal Models and Human Disease Mechanisms, Kunming Institute of Zoology, Chinese Academy of Sciences Kunming, Yunnan, China ; University of Chinese Academy of Sciences Beijing, China.
2: Key Laboratory of Animal Models and Human Disease Mechanisms, Kunming Institute of Zoology, Chinese Academy of Sciences Kunming, Yunnan, China.
3: Key Laboratory of Animal Models and Human Disease Mechanisms, Kunming Institute of Zoology, Chinese Academy of Sciences Kunming, Yunnan, China ; Kunming Primate Research Center, Kunming Institute of Zoology, Chinese Academy of Sciences Kunming, Yunnan, China ; Yunnan Key Laboratory of Primate Biomedical Research Kunming, Yunnan, China.

Articles cited by this

Neurocircuitry of addiction. Neuropsychopharmacology (2010) 14.22

What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Res Brain Res Rev (1998) 12.19

The debate over dopamine's role in reward: the case for incentive salience. Psychopharmacology (Berl) (2006) 9.18

A selective role for dopamine in stimulus-reward learning. Nature (2010) 5.57

Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addict Biol (2007) 4.78

A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci U S A (1983) 3.39

Addiction: a disease of learning and memory. Am J Psychiatry (2005) 3.26

The dopamine hypothesis of reward: past and current status. Trends Neurosci (1999) 2.68

Dopamine signaling in the dorsal striatum is essential for motivated behaviors: lessons from dopamine-deficient mice. Ann N Y Acad Sci (2008) 2.15

Molecular mechanisms of drug addiction. J Neurosci (1992) 1.88

Reward without dopamine. J Neurosci (2003) 1.80

Morphine reward in dopamine-deficient mice. Nature (2005) 1.66

1-Methyl-4-phenylpyridinium affects fast axonal transport by activation of caspase and protein kinase C. Proc Natl Acad Sci U S A (2007) 1.51

Neuronal circuits underlying acute morphine action on dopamine neurons. Proc Natl Acad Sci U S A (2011) 1.23

Stress-induced activation of the dynorphin/κ-opioid receptor system in the amygdala potentiates nicotine conditioned place preference. J Neurosci (2012) 1.18

Some determinants of morphine effects on intracranial self-stimulation in rats: dose, pretreatment time, repeated treatment, and rate dependence. Behav Pharmacol (2011) 1.16

A new model to study compensatory mechanisms in MPTP-treated monkeys exhibiting recovery. Brain (2007) 1.14

Striatal dopaminergic correlates of stable parkinsonism and degree of recovery in old-world primates one year after MPTP treatment. Neuroscience (2000) 1.05

Effects of dopamine antagonists with different receptor blockade profiles on morphine-induced place preference in male mice. Behav Brain Res (2001) 0.99

Developing a stable bilateral model of parkinsonism in rhesus monkeys. Neuroscience (1993) 0.98

Synaptic microcircuitry of tyrosine hydroxylase-containing neurons and terminals in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys. J Comp Neurol (2006) 0.90

Effect of morphine on conditioned place preference in rhesus monkeys. Addict Biol (2011) 0.87

Intracerebroventricular injection of interleukin-1 suppresses peripheral lymphocyte function in the primate. Neuroimmunomodulation (1997) 0.82

A new MRI approach for accurately implanting microelectrodes into deep brain structures of the rhesus monkey (Macaca mulatta). J Neurosci Methods (2010) 0.81

A quantitative approach to developing Parkinsonian monkeys (Macaca fascicularis) with intracerebroventricular 1-methyl-4-phenylpyridinium injections. J Neurosci Methods (2015) 0.79